Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity (Details) - Schedule of stock-based compensation expense

v3.21.2
Shareholders' Equity (Details) - Schedule of stock-based compensation expense - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Schedule of stock-based compensation expense [Abstract]        
Research and development options expense $ 79,604 $ 56,458 $ 223,413 $ 196,976
Total research and development expenses 79,604 56,458 223,413 196,976
General and administrative options expense 468,281 291,727 1,289,192 878,864
Stock and warrants issued to consultants and employees 640,992 329,807 1,844,254 685,238
Total general and administrative expenses 1,109,273 621,534 3,133,446 1,564,102
Total stock-based compensation expense $ 1,188,877 $ 677,992 $ 3,356,859 $ 1,761,078